Iveric Bio Stock Profit Margin
ISEEDelisted Stock | USD 39.95 0.00 0.00% |
IVERIC Bio fundamentals help investors to digest information that contributes to IVERIC Bio's financial success or failures. It also enables traders to predict the movement of IVERIC Stock. The fundamental analysis module provides a way to measure IVERIC Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IVERIC Bio stock.
IVERIC |
IVERIC Bio Company Profit Margin Analysis
IVERIC Bio's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, IVERIC Bio has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
IVERIC Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IVERIC Bio's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IVERIC Bio could also be used in its relative valuation, which is a method of valuing IVERIC Bio by comparing valuation metrics of similar companies.IVERIC Bio is currently under evaluation in profit margin category among its peers.
IVERIC Fundamentals
Return On Equity | -0.55 | |||
Return On Asset | -0.3 | |||
Current Valuation | 4.98 B | |||
Shares Outstanding | 137.98 M | |||
Shares Owned By Insiders | 0.65 % | |||
Shares Owned By Institutions | 99.35 % | |||
Number Of Shares Shorted | 16.64 M | |||
Price To Earning | 4.17 X | |||
Price To Book | 3.81 X | |||
Gross Profit | (117.01 M) | |||
EBITDA | (192.28 M) | |||
Net Income | (185.21 M) | |||
Cash And Equivalents | 311.96 M | |||
Cash Per Share | 2.64 X | |||
Total Debt | 97.77 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 11.98 X | |||
Book Value Per Share | 3.48 X | |||
Cash Flow From Operations | (163.77 M) | |||
Short Ratio | 5.25 X | |||
Earnings Per Share | (1.82) X | |||
Target Price | 39.1 | |||
Number Of Employees | 163 | |||
Beta | 1.1 | |||
Market Capitalization | 5.51 B | |||
Total Asset | 666.82 M | |||
Retained Earnings | (864.81 M) | |||
Working Capital | 627.24 M | |||
Current Asset | 121.07 M | |||
Current Liabilities | 14.54 M | |||
Z Score | 32.19 | |||
Net Asset | 666.82 M |
About IVERIC Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IVERIC Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IVERIC Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IVERIC Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in IVERIC Stock
If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |